Blanket Purchase Agreement 36F79724D0020-36C25225A0002

Award Date 10/1/24
Last Date to Order 9/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics. The single-award BPA, valued at up to $2,971,499.40, is for the supply of Biomerieux's proprietary reagents, diagnostic equipment, and associated maintenance services to the VA's VISN 17 network. The contract is established under the Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, enabling the VA to...
The Blanket Purchase Agreement (BPA) contract with Biomerieux Inc., a global leader in in vitro diagnostics, was awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs. The contract has a total ceiling value of $4,555,448.57 and a period of performance through May 31, 2026. The primary purpose of this contract is to provide VISN 15 with a comprehensive suite of Vitek microbiological testing supplies and maintenance services. This includes the...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 17 (VISN 17), a division of the U.S. Department of Veterans Affairs (VA), to Biomerieux Inc., a global leader in in vitro diagnostics. The single-award BPA, valued at up to $14.4 million over its 5-year period of performance, allows the VA to procure Biomerieux's proprietary BioFire diagnostic platforms, reagents, and test kits to support infectious disease testing and pathogen detection at VA healthcare...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE MOLECULAR TESTING products and services. The $209,568.78 contract, which has a period of performance through September 30, 2025, is under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. Biomerieux Inc., through its Biomerieux, Inc. division, will supply the VA with its...
The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23 (VISN 23), has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of test kit reagents and associated diagnostic platforms. This single-award BPA, with a total ceiling value of $14,732,632.16, is part of Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 (VISN 10) to Biomerieux Inc., a global leader in in vitro diagnostics. The $1,977,723.92 single-award BPA, which falls under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, is for the provision of analyzers, reagents, and consumables to support the agency's critical laboratory testing requirements. The contract includes two BPA calls, valued...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a Blanket Purchase Agreement (BPA) by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration under its Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III). The BPA and subsequent task orders, valued at over $1.4 million, provide the VA with Biomerieux's specialized microbiology testing platforms, reagents, test kits, and technical support services for blood culture...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 21 (VISN 21), a division of the U.S. Department of Veterans Affairs, to Biomerieux Inc. through its Biomerieux, Inc. division. The BPA has a ceiling value of $13,000,000 and a period of performance through January 31, 2030. The purpose of this BPA is to provide the VISN 21 healthcare network with a VISN-wide film array laboratory test system, including cost-per-test pricing for the associated clinical...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 23 (VISN 23), to Biomerieux Inc. through its Biomerieux, Inc. division. The single-award BPA, valued at $63,477.03, is established under the Multiple Award Schedule (MAS) contract vehicle and has a period of performance ending on September 30, 2024. The BPA call order is for microbiology identification and antibiotic susceptibility testing services to be...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 6, a component of the U.S. Department of Veterans Affairs, to the prime contractor Biomerieux Inc. through its Biomerieux, Inc. division. The contract has a ceiling value of $1,948,550.00 and a period of performance that extends through October 28, 2025. The purpose of this BPA is to procure automated blood culture analyzers, related consumables, and support services from Biomerieux. The contract...

This Blanket Purchase Agreement (BPA) contract is awarded by the U.S. Department of Veterans Affairs (VA), Integrated Service Network 12, to Biomerieux Inc., a global leader in in vitro diagnostics. The contract has a ceiling value of $6,266,226.72 and a period of performance through September 30, 2025.

Under this single-award BPA, Biomerieux will provide multiplex PCR reagents and consumables, including its proprietary VITEK, BioFire, and VIDAS diagnostic systems, to support infectious disease testing and pathogen detection across the VA healthcare operations. The contract is issued under Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits, allowing various government agencies to efficiently access the company's specialized clinical laboratory equipment and supplies. The awards do not involve any set-aside designations, as Biomerieux is often the sole source provider for its proprietary technologies.

Generated 3/29/25, 9:54 AM